Article Details
Retrieved on: 2020-12-10 13:01:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Dr. Michael F. Haller, Denovo <b>Biopharma's</b> Chief Business Officer, said, "Wuzhong Pharmaceutical's pioneering work on DB108 has laid a good ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here